Eagle Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $57M | Buy |
624,759
+353,723
| +131% | +$32.3M | 0.29% | 111 |
|
|
2024
Q2 | $18.4M | Sell |
271,036
-81,306
| -23% | -$5.53M | 0.1% | 195 |
|
|
2024
Q1 | $24.1M | Sell |
352,342
-83,376
| -19% | -$5.69M | 0.12% | 166 |
|
|
2023
Q4 | $31.2M | Buy |
435,718
+22,628
| +5% | +$1.62M | 0.17% | 146 |
|
|
2023
Q3 | $21.5M | Buy |
413,090
+14,290
| +4% | +$744K | 0.13% | 171 |
|
|
2023
Q2 | $25.3M | Buy |
398,800
+172,147
| +76% | +$10.9M | 0.14% | 159 |
|
|
2023
Q1 | $12.3M | Sell |
226,653
-40,183
| -15% | -$2.18M | 0.07% | 218 |
|
|
2022
Q4 | $13.8M | Buy |
266,836
+11,879
| +5% | +$614K | 0.08% | 200 |
|
|
2022
Q3 | $11.9M | Sell |
254,957
-6,500
| -2% | -$302K | 0.08% | 214 |
|
|
2022
Q2 | $14.9M | Buy |
+261,457
| New | +$14.9M | 0.09% | 201 |
|